Early life vaccination: Generation of adult-quality memory CD8+ T cells in infant mice using non-replicating adenoviral vectors

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Nazerai, Loulieta ^a   Bassi, Maria R ^a   Uddback, Ida E M ^a   Holst, Peter J ^a   Christensen, Jan P ^a   Thomsen, Allan R ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VACCINE;

ADENOVIRIDAE; ADENOVIRUS INFECTION; ADMINISTRATION AND DOSAGE; AGE; ANIMAL; CD8+ T LYMPHOCYTE; FEMALE; GENE VECTOR; GENETICS; IMMUNITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; MOUSE; PHENOTYPE; PROCEDURES; VACCINATION;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; AGE FACTORS; ANIMALS; BIOMARKERS; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENETIC VECTORS; IMMUNITY; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; MICE; PHENOTYPE; VACCINATION; VACCINES;

EID: 85002604782     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38666     Document Type: Article

References (58)

1. Adkins, B., Leclerc, C. & Marshall-Clarke, S. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4, 553-564 (2004).
2. Siegrist, C. A. Neonatal and early life vaccinology. Vaccine 19, 3331-3346 (2001).
3. Plotkin, S. A. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47, 401-409 (2008).
4. Wodarz, D. et al. A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment. Philos. Trans. R. Soc. Lond B Biol. Sci. 355, 329-343 (2000).
5. Belnoue, E., Fontannaz-Bozzotti, P., Grillet, S., Lambert, P. H. & Siegrist, C. A. Protracted course of lymphocytic choriomeningitis virus WE infection in early life: induction but limited expansion of CD8+ efector T cells and absence of memory CD8+ T cells. J. Virol. 81, 7338-7350 (2007).
6. Rudd, B. D. et al. Acute neonatal infections 'lock-in' a suboptimal CD8+ T cell repertoire with impaired recall responses. PLoS. Pathog. 9, e1003572 (2013).
7. Barrios, C. et al. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively difer from adult responses: predominance of a T2-biased pattern which persists afer adult boosting. Eur. J. Immunol. 26, 1489-1496 (1996).
8. Tomsen, A. R., Marker, O. & Volkert, M. The dual role of lymphocytic choriomeningitis virus-specifc antibodies. Med. Microbiol. Immunol. 175, 121-124 (1986).
9. Tomsen, A. R., Volkert, M. & Marker, O. Diferent isotype profiles of virus-specifc antibodies in acute and persistent lymphocytic choriomeningitis virus infection in mice. Immunology 55, 213-223 (1985).
10. Forsthuber, T., Yip, H. C. & Lehmann, P. V. Induction of TH1 and TH2 immunity in neonatal mice. Science 271, 1728-1730 (1996).
11. Ridge, J. P., Fuchs, E. J. & Matzinger, P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science 271, 1723-1726 (1996).
12. Sarzotti, M., Robbins, D. S. & Hofman, P. M. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271, 1726-1728 (1996).
13. Zaghouani, H., Hoeman, C. M. & Adkins, B. Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells. Trends Immunol. 30, 585-591 (2009).
14. Belnoue, E. et al. Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life. PLoS. One. 8, e85302 (2013).
15. Glezen, W. P. Efect of maternal antibodies on the infant immune response. Vaccine 21, 3389-3392 (2003).
16. Siegrist, C. A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and defnition of main determinants. Vaccine 21, 3406-3412 (2003).
17. Daeron, M. Fc receptor biology. Annu. Rev. Immunol. 15, 203-234 (1997).
18. Pihlgren, M. et al. Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responses. Vaccine 23, 329-335 (2004).
19. Dempsey, P. W., Allison, M. E., Akkaraju, S., Goodnow, C. C. & Fearon, D. T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348-350 (1996).
20. Fearon, D. T. & Carroll, M. C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18, 393-422 (2000).
21. Tomsen, A. R. & Marker, O. The complementary roles of cellular and humoral immunity in resistance to re-infection with LCM virus. Immunology 65, 9-15 (1988).
22. Morein, B., Abusugra, I. & Blomqvist, G. Immunity in neonates. Vet. Immunol. Immunopathol. 87, 207-213 (2002).
23. Holst, P. J. et al. MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines. J. Immunol. 180, 3339-3346 (2008).
24. Holst, P. J., Orskov, C., Tomsen, A. R. & Christensen, J. P. Quality of the transgene-specifc CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination. J. Immunol. 184, 4431-4439 (2010).
25. Krebs, P., Scandella, E., Odermatt, B. & Ludewig, B. Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus. J. Immunol. 174, 4559-4566 (2005).
26. Tatsis, N. et al. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 110, 1916-1923 (2007).
27. Yang, T. C. et al. The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity. J. Immunol. 176, 200-210 (2006).
28. Marker, O., Torner, A. G. & Volkert, M. The interplay between target organ concentrations of lymphocytic choriomeningitis virus and cell mediated immunity in baby mice. Acta Pathol. Microbiol. Scand. C. 84, 23-30 (1976).
29. Jensen, S. et al. Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage. J. Immunol. 191, 4152-4164 (2013).
30. Holst, P. J. et al. MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines. J. Immunol. 180, 3339-3346 (2008).
31. Moskophidis, D., Cobbold, S. P., Waldmann, H. & Lehmann-Grube, F. Mechanism of recovery from acute virus infection: treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61, 1867-1874 (1987).
32. Nolz, J. C. & Harty, J. T. Protective capacity of memory CD8+ T cells is dictated by antigen exposure history and nature of the infection. Immunity. 34, 781-793 (2011).
33. Bassi, M. R. et al. Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice. PLoS. Negl. Trop. Dis. 10, e0004464 (2016).
34. West, E. E. et al. Tight regulation of memory CD8(+) T cells limits their efectiveness during sustained high viral load. Immunity. 35, 285-298 (2011).
35. Olson, J. A., McDonald-Hyman, C., Jameson, S. C. & Hamilton, S. E. Efector-like CD8(+) T cells in the memory population mediate potent protective immunity. Immunity. 38, 1250-1260 (2013).
36. Bro-Jorgensen, K. & Volkert, M. Defects in the immune system of mice infected with lymphocytic choriomeningitis virus. Infect. Immun. 9, 605-614 (1974).
37. Stefensen, M. A. et al. Pre-existing vector immunity does not prevent replication defcient adenovirus from inducing efcient CD8 T-cell memory and recall responses. PLoS. One. 7, e34884 (2012).
38. Stefensen, M. A. et al. Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation. J. Virol. 87, 6283-6295 (2013).
39. Andreasen, S. O., Christensen, J. E., Marker, O. & Tomsen, A. R. Role of CD40 ligand and CD28 in induction and maintenance of antiviral CD8+ efector T cell responses. J. Immunol. 164, 3689-3697 (2000).
40. Aaby, P. et al. Increased female-male mortality ratio associated with inactivated polio and diphtheria-tetanus-pertussis vaccines: Observations from vaccination trials in Guinea-Bissau. Pediatr. Infect. Dis. J. 26, 247-252 (2007).
41. Aaby, P., Ibrahim, S. A., Libman, M. D. & Jensen, H. The sequence of vaccinations and increased female mortality afer high-titre measles vaccine: trials from rural Sudan and Kinshasa. Vaccine 24, 2764-2771 (2006).
42. Moulton, L. H. et al. Evaluation of non-specifc efects of infant immunizations on early infant mortality in a southern Indian population. Trop. Med. Int. Health 10, 947-955 (2005).
43. Rudd, B. D. et al. Acute neonatal infections 'lock-in' a suboptimal CD8+ T cell repertoire with impaired recall responses. PLoS. Pathog. 9, e1003572 (2013).
44. Venturi, V. et al. The Neonatal CD8+ T Cell Repertoire Rapidly Diversifes during Persistent Viral Infection. J. Immunol. 196, 1604-1616 (2016).
45. Tatsis, N. et al. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines. Blood 110, 1916-1923 (2007).
46. Finn, J. D. et al. Persistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus. J. Virol. 83, 12027-12036 (2009).
47. La Gruta, N. L., Doherty, P. C. & Turner, S. J. A correlation between function and selected measures of T cell avidity in infuenza virus-specifc CD8+ T cell responses. Eur. J. Immunol. 36, 2951-2959 (2006).
48. Kolumam, G. A., Tomas, S., Tompson, L. J., Sprent, J. & Murali-Krishna, K. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202, 637-650 (2005).
49. Aichele, P. et al. CD8 T cells specifc for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion. J. Immunol. 176, 4525-4529 (2006).
50. Quinn, K. M. et al. Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling. J. Clin. Invest 125, 1129-1146 (2015).
51. Bonilla, W. V. et al. The alarmin interleukin-33 drives protective antiviral CD8(+) T cell responses. Science 335, 984-989 (2012).
52. Kollmann, T. R. et al. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 183, 7150-7160 (2009).
53. Elahi, S. New insight into an old concept: role of immature erythroid cells in immune pathogenesis of neonatal infection. Front Immunol. 5, 376 (2014).
54. Siegrist, C. A. et al. Induction of neonatal TH1 and CTL responses by live viral vaccines: a role for replication patterns within antigen presenting cells? Vaccine 16, 1473-1478 (1998).
55. Becker, T. C. et al. Use of recombinant adenovirus for metabolic engineering of mammalian cells. Methods Cell Biol. 43 Pt A, 161-189 (1994).
56. Barber, D. L., Wherry, E. J. & Ahmed, R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J. Immunol. 171, 27-31 (2003).
57. Bassi, M. R. et al. CD8+ T cells complement antibodies in protecting against yellow fever virus. J. Immunol. 194, 1141-1153 (2015).
58. Cobbold, S. P., Jayasuriya, A., Nash, A., Prospero, T. D. & Waldmann, H. Terapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature 312, 548-551 (1984).